Market research
PCLO.V PharmaCielo Ltd
V CAD Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 11M
- P/E ratio
- Not available
- Analyst target
- 2.5
- Dividend yield
- Not available
- Beta
- 0.62
Profile
Instrument facts
- Exchange
- V
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- CA71716K1012
- Market cap
- 11M
- P/E ratio
- Not available
- Analyst target
- 2.5
- Dividend yield
- Not available
- Beta
- 0.62
About
About PharmaCielo Ltd
PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. It offers medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies. PharmaCielo Ltd. is headquartered in Toronto, Canada.
Research context
PharmaCielo Ltd appears in PyInvesting’s TSX Venture Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the PCLO.V discussion.
5 years, 6 months ago
PharmaCielo Ltd is currently in a long term downtrend where the price is trading 13.2% below its 200 day moving average.
From a valuation standpoint, the stock is 91.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 84.7.
PharmaCielo Ltd's total revenue sank by 80.1% to $26K since the same quarter in the previous year.
Its net income has dropped by 60.0% to $-6M since the same quarter in the previous year.
Finally, its free cash flow grew by 40.7% to $-7M since the same quarter in the previous year.
Based on the above factors, PharmaCielo Ltd gets an overall score of 2/5.